XIAMEN DUOWEIMA TRADING CO., LTD. – Trademark Portfolio

Entity Type: 11

XIAMEN DUOWEIMA TRADING CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 22 (Cordage) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CHLORAX and GRAND ATTACK. The owner is based in XIAMEN.

AREA A, UNIT 1201, BLDG 1, XINGLINWAN

OPERATION, CENTER, JIMEI DISTRICT

XIAMEN 362200 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

XIAMEN DUOWEIMA TRADING CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

22
Cordage (1 filing)

Ropes, string, nets, tents, awnings, tarpaulins, sails, sacks and bags

Frequently Asked Questions

How many trademarks does XIAMEN DUOWEIMA TRADING CO., LTD. have?

XIAMEN DUOWEIMA TRADING CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does XIAMEN DUOWEIMA TRADING CO., LTD. file in?

XIAMEN DUOWEIMA TRADING CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 22 (Cordage). Class 25 covers clothing, footwear, headgear.

What are XIAMEN DUOWEIMA TRADING CO., LTD.'s most well-known trademarks?

XIAMEN DUOWEIMA TRADING CO., LTD.'s registered trademark portfolio includes well-known marks such as CHLORAX and GRAND ATTACK. These are among 2 currently registered trademarks in the portfolio.

What is XIAMEN DUOWEIMA TRADING CO., LTD.'s trademark registration success rate?

XIAMEN DUOWEIMA TRADING CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.